Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A particular
drug used inchemotherapy .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word satraplatin.
Examples
-
Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for diabetic foot ulcers.
-
Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for diabetic foot ulcers.
-
Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for diabetic foot ulcers.
-
Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for diabetic foot ulcers.
-
Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for diabetic foot ulcers.
-
Spectrum Pharmaceuticals has announced that the New Drug Application (NDA) for satraplatin has been ...
THE MEDICAL NEWS 2010
-
Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for diabetic foot ulcers.
-
GPC Biotech's stock took a major beating in July 2007, when FDA's advisory committee voted against the approval of satraplatin for prostate cancer.
GEN News Highlights 2009
-
The firm will also evaluate GPC Biotech's satraplatin, initially in prostate cancer, and Phase I RGB-286638.
GEN News Highlights 2009
-
The Company currently has two programs in clinical development: satraplatin, an oral platinum compound and RGB-286638, a multi-targeted protein kinase inhibitor.
unknown title 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.